EUVIMEDOpdag EUVIMED
Crossref

Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527

Yue Shi, Jinyao Zhang, Zheng Ma iD, Yongyong Zhang, Andreas Bechthold, Xiaoping Yu

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28347 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2023. Written by Yue Shi and 5 co-authors. Institution: Zhejiang Provincial Key Laboratory of Biometrology and Inspection & Quarantine, College of Life Sciences, China Jiliang University, Hangzhou, Zhejian…. Major MEDLINE topics: Oxytetracycline, Streptomyces rimosus. Cited 3 times so far (Crossref); 63 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In Streptomyces rimosus M527, the oxytetracycline (OTC) biosynthetic gene cluster is not expressed under laboratory conditions. In this study a reported‐guided mutant selection (RGMS) procedure was used to activate the cluster. The double‐reporter plasmid pAGT was constructed in which gusA encoding a β‐glucuronidase and tsr encoding a thiostrepton resistance methyltransferase were placed under the control of the native promoter of oxyA gene (P oxyA ). Plasmid pAGT was introduced and integrated into the chromosome of S. rimosus M527 by conjugation, yielding initial strain M527‐pAGT. Subsequently, mutants of M527‐pAGT were generated by using ribosome engineering technology. The mutants harboring activated OTC gene cluster were selected based on visual observation of GUS activity and thiostrepton resistance. Finally, mutant M527‐pAGT‐R7 was selected producing OTC in a concentration of 235.2 mg/L. In this mutant transcriptional levels of oxy sr genes especial oxyA sr gene were increased compared to wild‐type strain S. rimosus M527. The mutant M527‐pAGT‐R7 showed antagonistic activities against Gram‐negative and Gram‐positive strains. All data indicate that the OTC gene cluster was successfully activated using the RGMS method.

Subjects

MeSH terms (MEDLINE)

OxytetracyclineStreptomyces rimosusThiostreptonMultigene FamilyPromoter Regions, Genetic

Author keywords

Streptomyces rimosus M527activation of silent gene clusterdouble-reporter-guidedoxytetracyclineribosome engineering

Substances

OxytetracyclineThiostrepton

Authors and institutions

  • Zhejiang Provincial Key Laboratory of Biometrology and Inspection & Quarantine, College of Life Sciences, China Jiliang University, Hangzhou, Zhejiang Province, China.
  • Institute for Pharmaceutical Sciences, Pharmaceutical Biology and Biotechnology, University of Freiburg, Freiburg, Germany.

ORCID profiles: Zheng Ma

Cite

APA

Shi, Y., Zhang, J., Ma, Z., Zhang, Y., Bechthold, A., & Yu, X. (2023). Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28347

Vancouver

Shi Y, Zhang J, Ma Z, Zhang Y, Bechthold A, Yu X. Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28347

BibTeX
@article{Shi2023,
  author = {Shi, Yue and Zhang, Jinyao and Ma, Zheng and Zhang, Yongyong and Bechthold, Andreas and Yu, Xiaoping},
  title = {Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28347}
}
Start for free →